A Candidate Gene Study of Folate-Associated One Carbon Metabolism Genes and Colorectal Cancer Risk
- 1 July 2010
- journal article
- research article
- Published by American Association for Cancer Research (AACR) in Cancer Epidemiology, Biomarkers & Prevention
- Vol. 19 (7) , 1812-1821
Abstract
Background: Folate-associated one-carbon metabolism (FOCM) may play an important role in colorectal carcinogenesis. Variation in FOCM genes may explain some of the underlying risk of colorectal cancer. Methods: This study utilized data from 1,805 population-based colorectal cancer cases and 2,878 matched sibling controls from the Colon Cancer Family Registry. We used a comprehensive haplotype tagging single nucleotide polymorphism (tagSNP) approach to select 395 tagSNPs in 15 genes involved in folate and vitamin B12 metabolism. Genotyping was done using the Illumina GoldenGate or Sequenom platforms. Risk factor and dietary data were collected using self-completed questionnaires. Microsatellite instability (MSI) status was determined using standard techniques, and tumor subsite was obtained from pathology reports. The association between SNPs and colorectal cancer was assessed using conditional logistic regression with sibships as the matching factor and assuming a log additive or codominant model. Results: In the log additive model, two linked (r2 = 0.99) tagSNPs in the DHFR gene (rs1677693 and rs1643659) were associated with a significant decrease in colorectal cancer risk after correction for multiple testing (odds ratio, 0.87; 95% confidence interval, 0.71-0.94; P = 0.029; and odds ratio, 0.87; 95% confidence interval, 0.71-0.95; P = 0.034 for rs1677693 and rs1643659, respectively). These two linked (r2 = 0.99) tagSNPs and one tagSNP in the MTR gene (rs4659744) were significantly associated with reduced colorectal cancer risk only among individuals not using multivitamin supplements. Conclusions: Overall, we found only moderate evidence that genetic variation in 15 folate pathway genes may affect colorectal cancer risk except in non–multivitamin users. Impact: This study suggests that multivitamin supplement use may modify the association between folate pathway genes and colorectal cancer risk in a post-folic-acid-supplemented population. Cancer Epidemiol Biomarkers Prev; 19(7); 1812–21. ©2010 AACR.Keywords
All Related Versions
This publication has 73 references indexed in Scilit:
- Genes involved with folate uptake and distribution and their association with colorectal cancer riskCancer Causes & Control, 2009
- Methionine synthase A2756G polymorphism and cancer risk: a meta-analysisEuropean Journal of Human Genetics, 2009
- The extremely slow and variable activity of dihydrofolate reductase in human liver and its implications for high folic acid intakeProceedings of the National Academy of Sciences, 2009
- Folic Acid and Risk of Prostate Cancer: Results From a Randomized Clinical TrialJNCI: Journal of the National Cancer Institute, 2009
- So Many Correlated Tests, So Little Time! Rapid Adjustment of P Values for Multiple Correlated TestsThe American Journal of Human Genetics, 2007
- Genetic polymorphisms in one-carbon metabolism: associations with CpG island methylator phenotype (CIMP) in colon cancer and the modifying effects of dietCarcinogenesis, 2007
- The Epigenomics of CancerCell, 2007
- Dietary intake of folate and co-factors in folate metabolism, MTHFR polymorphisms, and reduced rectal cancerCancer Causes & Control, 2007
- Haploview: analysis and visualization of LD and haplotype mapsBioinformatics, 2004
- DNA methylation in cancer: too much, but also too littleOncogene, 2002